NCT02307851View on ClinicalTrials.gov

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent VLP Vaccine

BIOLOGICAL

Comparator TIV

Trial Locations (5)

33143

Miami Research Associates, Miami

66219

Johnson County Clin Trials, Lenexa

68134

Meridian Clinical Research, Omaha

78229

Clinical Trials of Texas, San Antonio

92801

Anaheim Clinical Trials, Anaheim

Sponsors

Lead Sponsor

Novavax
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Novavax

INDUSTRY